Building a National Cohort Eric Boerwinkle; February, 2015 - - PowerPoint PPT Presentation

building a national cohort
SMART_READER_LITE
LIVE PREVIEW

Building a National Cohort Eric Boerwinkle; February, 2015 - - PowerPoint PPT Presentation

Building a National Cohort Eric Boerwinkle; February, 2015 Precision Medicine Workshop What is a Cohort? Sample of people Who share some characteristic (e.g. a place) and time frame Cohort study Longitudinal


slide-1
SLIDE 1

Building a National Cohort

Eric Boerwinkle; February, 2015 Precision Medicine Workshop

slide-2
SLIDE 2

What is a Cohort?

  • Sample of people
  • Who share some characteristic (e.g. a place) and

time frame

  • Cohort study

– Longitudinal – Measure/monitor/estimate some things – Assess outcomes (usually in the future)

  • Does not have to be a representative sample, but

clear eligibility criteria allow making generalizable inferences.

slide-3
SLIDE 3

Prospective, longitudinal follow-up. Deep phenotyping for RFs and outcomes. Similar methods and QC for phenotyping. Available DNA, RNA, blood, imaging.

CHARGE (Cohorts for Heart & Aging Research in Genome Epidemiology) Consortium, N>>100,000

FHS N~9,400 ARIC N~16,000 Jackson Heart Study n~5,300 Study of Latinos N~16,000 Deeply Phenotyped Risk Factors and Disease Array Genotypes and Sequence CHS N~5,000

>600 Investigators, >80 Cohorts >60 Phenotype Working Groups Published Collaboration Principles >370 Publications since 2008

*Psaty BM, O’Donnell CJ, et al. Circulation CV Genetics 2009.

MESA, FamHeart, JHS, CARDIA n~20,000

slide-4
SLIDE 4

CHARGE (Cohorts for Heart & Aging Research in Genome Epidemiology) Consortium, N>>100,000

FHS N~9,400 ARIC N~16,000 Jackson Heart Study n~5,300 Study of Latinos N~16,000 Deeply Phenotyped Risk Factors and Disease Array Genotypes and Sequence CHS N~5,000

>600 Investigators, >80 Cohorts >60 Phenotype Working Groups Published Collaboration Principles >140 Publications since 2008

MESA, FamHeart, JHS, CARDIA n~20,000

slide-5
SLIDE 5

Sequencing in Cohorts

  • Update

– WES (N=11,500)(F4) – WGS (N=5,700) – Collaborations (ESP) (N=23,000) – Strong analytic infrastructure

5

Morrison A. Nat Genet 2013; 45: 899-901.

FHS: phs000651.v4.p9; CHS: phs000667.v1.p1; ARIC phs000668.v1.p1

slide-6
SLIDE 6

Building a National Cohort

Consortium Of Cohorts A National Cohort

Artist: Chuck Close

slide-7
SLIDE 7

Building A National Cohort

  • Harmonization
  • Big Data Challenges
  • Storage
  • Analytics
  • Connectivity

The CHARGE Data Commons

Technical Challenges Enhanced Opportunities

  • Participatory
  • Enhanced phenotyping
  • Platform for clinical trials
  • Pilot for national health/EMRs
  • Enhanced community resources
  • Virtuous cycle of health care and research
slide-8
SLIDE 8

HAL histidine Incident HF Incident CHD Incident CKD p = 1.2×10-13 p = 2.6×10-6 p = 1.9×10-5 p = 1.4×10-4

splice (n =1) R322X (n = 22)

15 4 16 12 3

splice (n =1)

Gene Metabolite Clinical Endpoints 8

Clinical and Biologic Continuum of Simple/Complex and Rare/Common

PCSK9, Cohen, 2006; PMID: 16554528 APOC3, Crosby, 2013; PMID: 24941081 NPC1L1, Stitziel, 2014; PMID: 25390462 PLA2G7, Polfus, 2015;

slide-9
SLIDE 9

Few Actionable Alleles Missing ‘Heritability’

Rare Mendelian……….. ‘Oligogenic’ ……………. Common Complex

Low frequency/High impact Not related to sporadic cases in a simple way

Jim Lupski Richard Gibbs Eric Boerwinkle

Clinical and Biologic Continuum of Simple/Complex and Rare/Common

slide-10
SLIDE 10

Building a National Cohort

A National Cohort Virtuous Cycle of Health Care and Research